U.S Class(es): 021, 023, 026, 036, 038
Class Status: Active
U.S Class(es): 002, 027, 028, 050
Class Status: Active
U.S Class(es): 001, 002, 003, 022, 041
Class Status: Active
U.S Class(es): 022, 039
Class Status: Active
| Name | CHARLES T. J. WEIGELL FROSS ZELNICK LEHRMAN & ZISSU, P.C. |
|---|---|
| Address | 151 W. 42ND STREET, 17TH FLOOR NEW YORK, NY 10036 UNITED STATES |
| Date | Description | Action Tags | Code |
|---|---|---|---|
| Sep-15-2023 | NEW APPLICATION ENTERED | NWAPI | |
| Oct-02-2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
| Sep-15-2023 | TEAS VOLUNTARY AMENDMENT RECEIVED | PARII | |
| Sep-15-2023 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | TAEAI | |
| Jan-25-2024 | ASSIGNED TO EXAMINER | DOCKD | |
| Jan-31-2024 | NON-FINAL ACTION WRITTEN | CNRTR | |
| Jan-31-2024 | NON-FINAL ACTION E-MAILED | GNRTF | |
| Jan-31-2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | GNRNO | |
| Apr-24-2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | TROAI | |
| Apr-24-2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE | CRFAI | |
| Apr-24-2024 | TEAS/EMAIL CORRESPONDENCE ENTERED | TEMEI | |
| Sep-10-2024 | FINAL REFUSAL WRITTEN | CNFRR | |
| Sep-10-2024 | FINAL REFUSAL E-MAILED | GNFRO | |
| Sep-10-2024 | NOTIFICATION OF FINAL REFUSAL EMAILED | GNFNO | |
| Nov-08-2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | XELRI | |
| Nov-08-2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | XELGO | |
| Jan-15-2025 | TEAS REQUEST FOR RECONSIDERATION RECEIVED | ERFRI | |
| Jan-15-2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE | CRFAI | |
| Jan-15-2025 | TEAS/EMAIL CORRESPONDENCE ENTERED | TEMEI | |
| Mar-07-2025 | EXPARTE APPEAL RECEIVED AT TTAB | EXAFT | |
| Mar-07-2025 | JURISDICTION RESTORED TO EXAMINING ATTORNEY | JURTT | |
| Mar-07-2025 | EX PARTE APPEAL-INSTITUTED | EXPIT | |
| Oct-03-2025 | ASSIGNED TO EXAMINER | DOCKD | |
| Nov-03-2025 | SUBSEQUENT FINAL REFUSAL WRITTEN | CFRCR | |
| Nov-03-2025 | SUBSEQUENT FINAL EMAILED | GNSFO | |
| Nov-03-2025 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | GNS1O |